StockNews.com downgraded shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday morning. A number of other equities research ...
A new study has found that people who spend time on their devices in bed are likely to suffer from sleep loss and insomnia.
Shares of ResMed Inc. RMD slid 3.83% to $205.17 Friday, on what proved to be an all-around dismal trading session for the ...
The recent share market selloff has rattled investor confidence â but for those thinking long term, it could be a gift in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback